MDL | - |
---|---|
Molecular Weight | 394.92 |
Molecular Formula | C19H23ClN2O3S |
SMILES | ClC1=CC=C(OC)C(NC[C@H]2C(C)(C)[C@@H]2C3=CC=C(S(N)(=O)=O)C=C3)=C1 |
BNC375 significantly potentiates the acetylcholine signal without changing the rapid receptor desensitization [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
BNC375 (0.003-10.0 mg/kg, administered orally) exhibits the MED of 0.03 mg/kg, and achieves full reversal of the Scopolamine-induced impairment at 1.0 mg/kg in mouse T-maze model. BNC375 exhibits the plasm half-life (t 1/2 ) of 1.2 h [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 83.33 mg/mL ( 211.00 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.5322 mL | 12.6608 mL | 25.3216 mL |
5 mM | 0.5064 mL | 2.5322 mL | 5.0643 mL |
10 mM | 0.2532 mL | 1.2661 mL | 2.5322 mL |